The M&A Hunter

Substack by The M&A Hunter · launched Nov 3, 2025

Tracking biotech acquisition targets before big pharma strikes. Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"

Paid leaderboard
#423
Subscribers
2.0K

rounded by Substack

Paid subscribers
100+ paid
Badge
Bestseller 100
Followers
4.3K
Paid plan
$14/mo
Recommends
60

other newsletters

Growth history

Subscribers (thousands, nightly)

2.0K on Sep 10, 2026 → 2.0K on Sep 30, 2026

Followers (thousands, nightly)

Stats worth sharing

Tracked since Sep 10, 2026 — 21 daily snapshots so far. The card below is built from what we track and refreshes nightly.

Followers added
+181

since tracking began

The M&A Hunter — rank, subscribers and growth, tracked by Stock Market Watch
Download PNGShare on X

Recent posts

No posts collected for this newsletter yet.

← All trending finance newsletters

Data: Substack public leaderboards and publication archives, refreshed nightly, plus public beehiiv sitemaps and recommendation pages, refreshed weekly. Source for this page: The M&A Hunter. Subscriber counts are Substack’s own rounded public figures, so week-on-week changes move in steps. beehiiv audience sizes are self-reported by the publisher and are not verified. Last snapshot: Sep 30, 2026.